Substituted pyrrolidines and methods of use
US9981910B2 · kind B2 · utility
28Cited by
2References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 5, 2017 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Oct 5, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention discloses compounds of Formula (I)wherein R1, R2, R2A, R3, R3A, R4, R4A, and R5 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.